Results 61 to 70 of about 4,615,353 (309)
AGENCY COSTS, RISK SHOCKS, AND INTERNATIONAL CYCLES [PDF]
Macroeconomic Dynamics, 2017 We add agency costs into a two-country, two-good international business-cycle model. In our model, changes in the relative price of investment arise endogenously. Despite the fact that technology shocks are uncorrelated across countries, the relative price of investment is positively correlated across countries in our model, much as it is in detrended ...
Letendre, Marc-André, Wagner, Joel
openaire +2 more sources
New Directions for Adult and Continuing Education, EarlyView.ABSTRACT Advancing artificial intelligence (AI) has transformed learning and work, yet higher education and professional development programs have not systematically equipped learners for AI‐prevalent environments. This lack of preparation creates uncertainty regarding control, responsibility, trust, and accountability.
Moon‐Heum Cho, Jerusalem Merkebu
wiley +1 more source
Analisis Pengaruh Struktur Modal, Ukuran Perusahaan, dan Agency Cost Terhadap Kinerja Perusahaan
Jurnal Akuntansi dan Keuangan, 2011 Penelitian ini bertujuan untuk menguji pengaruh struktur modal dan ukuran perusahaan terhadap agency cost; pengaruh struktur modal, ukuran perusahaan, dan agency cost terhadap kinerja perusahaan; serta pengaruh tidak langsung struktur modal dan ukuran ...
Khaira Amalia Fachrudin
doaj
Excessive continuation and dynamic agency costs of debt [PDF]
European Economic Review, 2002 Abstract This paper analyses the incentives of the equityholders of a leveraged company to shut it down in a continuous time, stochastic environment. Keeping the firm as an ongoing concern has an option value but equity and debt holders value it differently. Equityholders’ decisions exhibit excessive continuation and reduce firm's value.
Décamps, Jean-Paul +1 more
openaire +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Copernican Journal of Finance & Accounting, 2019 In this research, the mixed strategy complete information static game was adopted to explain the effect of mandatory dividend policy on agency cost, and Chinese mandatory dividend policy introduced in 2011was regarded as the institutional background, and
Qin Hailin, Zhang Jingxu
doaj +3 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
China Accounting and Finance ReviewThis paper explores the association between directors’ and officers’ liability insurance (D&O insurance) and management tone manipulation. This study uses data from A-share listed non-financial companies from 2009 to 2021 as its sample for empirical ...
Wei Xiong +3 more
doaj +1 more source
, 2020 The corporate cash holdings are important when deciding performance and profitability of firms, and also as an extension to shareholders’ wealth. The issue of the amount of cash holdings in firms does not solely impact the firms’ balance sheets and ...
Mohd Ashhari, Zariyawati +2 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source